KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Halozyme Therapeutics (HALO) Times Interest Earned (2016 - 2025)

Halozyme Therapeutics (HALO) has disclosed Times Interest Earned for 13 consecutive years, with -$18.91 as the latest value for Q4 2025.

  • On a quarterly basis, Times Interest Earned fell 148.93% to -$18.91 in Q4 2025 year-over-year; TTM through Dec 2025 was $25.87, a 15.1% decrease, with the full-year FY2025 number at $25.87, down 15.1% from a year prior.
  • Times Interest Earned was -$18.91 for Q4 2025 at Halozyme Therapeutics, down from $50.73 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $53.11 in Q2 2021 to a low of -$18.91 in Q4 2025.
  • A 5-year average of $26.69 and a median of $25.87 in 2021 define the central range for Times Interest Earned.
  • Peak YoY movement for Times Interest Earned: soared 4384.26% in 2021, then crashed 148.93% in 2025.
  • Halozyme Therapeutics' Times Interest Earned stood at $27.51 in 2021, then tumbled by 40.74% to $16.3 in 2022, then rose by 18.72% to $19.36 in 2023, then soared by 99.72% to $38.66 in 2024, then plummeted by 148.93% to -$18.91 in 2025.
  • Per Business Quant, the three most recent readings for HALO's Times Interest Earned are -$18.91 (Q4 2025), $50.73 (Q3 2025), and $46.07 (Q2 2025).